Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Biol ; 15(9): 5196-202, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7651437

ABSTRACT

Critical determinants of DNA recognition by p53 have been identified by a molecular genetic approach. The wild-type human p53 fragment containing amino acids 71 to 330 (p53(71-330)) was used for in vitro DNA binding assays, and full-length human p53 was used for transactivation assays with Saccharomyces cerevisiae. First, we defined the DNA binding specificity of the wild-type p53 fragment by using systematically altered forms of a known consensus DNA site. This refinement indicates that p53 binds with high affinity to two repeats of PuGPuCA.TGPyCPy, a further refinement of an earlier defined consensus half site PuPuPuC(A/T).(T/A) GPyPyPy. These results were further confirmed by transactivation assays of yeast by using full-length human p53 and systematically altered DNA sites. Dimers of the pentamer AGGCA oriented either head-to-head or tail-to-tail bound efficiently, but transactivation was facilitated only through head-to-head dimers. To determine the origins of specificity in DNA binding by p53, we identified mutations that lead to altered specificities of DNA binding. Single-amino-acid substitutions were made at several positions within the DNA binding domain of p53, and this set of p53 point mutants were tested with DNA site variants for DNA binding. DNA binding analyses showed that the mutants Lys-120 to Asn, Cys-277 to Gln or Arg, and Arg-283 to Gln bind to sites with noncanonical base pair changes at positions 2, 3, and 1 in the pentamer (PuGPuCA), respectively. Thus, we implicate these residues in amino acid-base pair contacts. Interestingly, mutant Cys-277 to Gln bound a consensus site as two and four monomers, as opposed to the wild-type p53 fragment, which invariably binds this site as four monomers.


Subject(s)
DNA/metabolism , Point Mutation , Tumor Suppressor Protein p53/metabolism , Base Sequence , Binding Sites/genetics , Consensus Sequence , Cross-Linking Reagents , DNA/genetics , Humans , Molecular Sequence Data , Peptide Fragments/metabolism , Protein Binding , Repetitive Sequences, Nucleic Acid , Saccharomyces cerevisiae/genetics , Transcriptional Activation , Tumor Suppressor Protein p53/genetics
2.
Mol Cell Biol ; 14(12): 8315-21, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7969167

ABSTRACT

We identified a minimal domain of human p53 required for the transactivation of a p53 response element in Saccharomyces cerevisiae. This domain contains the central region of p53 sufficient for specific DNA binding, which colocalizes with the region responsible for binding simian virus 40 large T antigen, 53BP1, and 53BP2. Thirty amino acid positions, including natural mutational hot spots (R175, R213, R248, R249, and R273), in the minimal DNA-binding domain were mutated by alanine substitution. Alanine substitutions at positions R213, R248, R249, D281, R282, R283, E286, and N288 affected transactivation but allowed binding to at least one of the three interacting proteins; these amino acids may be involved in amino acid-base pair contacts. Surprisingly, alanine substitution at the mutational hot spot R175 did not affect DNA binding, transactivation, or T-antigen binding, although it nearly eliminated binding to 53BP1 and 53BP2. Mutation of H168 significantly affected only T-antigen binding, and mutation of E285 affected only 53BP1 binding. Thus, we implicate specific residues of p53 in different DNA and protein interactions.


Subject(s)
Antigens, Polyomavirus Transforming/chemistry , Carrier Proteins/metabolism , DNA-Binding Proteins/chemistry , Intracellular Signaling Peptides and Proteins , Phosphoproteins , Tumor Suppressor Protein p53/chemistry , Amino Acid Sequence , Antigens, Polyomavirus Transforming/metabolism , Apoptosis Regulatory Proteins , Binding Sites , DNA-Binding Proteins/metabolism , Humans , In Vitro Techniques , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Binding , Structure-Activity Relationship , Transcriptional Activation , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor p53-Binding Protein 1
SELECTION OF CITATIONS
SEARCH DETAIL
...